Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126427162 | 12642716 | 2 | F | 20160807 | 20160808 | 20160810 | 20160815 | EXP | BR-ASTRAZENECA-2016SE85945 | ASTRAZENECA | 23785.00 | DY | F | Y | 56.00000 | KG | 20160815 | PH | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126427162 | 12642716 | 1 | PS | ARIMIDEX | ANASTROZOLE | 1 | Oral | DAILY | 20541 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126427162 | 12642716 | 1 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126427162 | 12642716 | DS |
| 126427162 | 12642716 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126427162 | 12642716 | Diplegia | |
| 126427162 | 12642716 | Headache | |
| 126427162 | 12642716 | Nausea | |
| 126427162 | 12642716 | Tinnitus | |
| 126427162 | 12642716 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126427162 | 12642716 | 1 | 20160807 | 0 |